These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38775722)
1. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways. Jiang XX; Zhang R; Wang HS Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722 [TBL] [Abstract][Full Text] [Related]
2. SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/smad2/3 signalling pathway. Hu HJ; Wang XH; Zhang ZZ; Ou Y; Ning ZH; Yang JY; Huang H; Tang HF; Jiang ZS Eur J Pharmacol; 2024 Nov; 982():176900. PubMed ID: 39168432 [TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms. Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367 [TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury. Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes. Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261 [TBL] [Abstract][Full Text] [Related]
7. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway. Wu Y; Can J; Hao S; Qiang X; Ning Z Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064 [TBL] [Abstract][Full Text] [Related]
8. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice. Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100 [TBL] [Abstract][Full Text] [Related]
9. Neferine inhibits angiotensin II-stimulated proliferation in vascular smooth muscle cells through heme oxygenase-1. Li XC; Tong GX; Zhang Y; Liu SX; Jin QH; Chen HH; Chen P Acta Pharmacol Sin; 2010 Jun; 31(6):679-86. PubMed ID: 20523338 [TBL] [Abstract][Full Text] [Related]
10. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice. Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin I Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF- He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548 [TBL] [Abstract][Full Text] [Related]
13. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice. Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551 [TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling. Zhan G; Wang X; Wang X; Li J; Tang Y; Bi H; Yang X; Xia Y Eur J Pharmacol; 2024 Sep; 978():176712. PubMed ID: 38906237 [TBL] [Abstract][Full Text] [Related]
15. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation. Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026 [TBL] [Abstract][Full Text] [Related]
16. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway. Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice. Bi HL; Zhang YL; Yang J; Shu Q; Yang XL; Yan X; Chen C; Li Z; Li HH Hypertens Res; 2020 Mar; 43(3):168-177. PubMed ID: 31700166 [TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293 [TBL] [Abstract][Full Text] [Related]
19. Xu B; Xu Y; Ren W; Meng S; Hong T; Cao Z; Xiao X; Guo X; Yu L; Zhao J; Wang H Food Funct; 2024 Sep; 15(18):9165-9175. PubMed ID: 39157962 [TBL] [Abstract][Full Text] [Related]
20. Costunolide ameliorates angiotensin II-induced atrial inflammation and fibrosis by regulating mitochondrial function and oxidative stress in mice: A possible therapeutic approach for atrial fibrillation. Liu Y; Wang D; Jin Y; Sun G; Lou Q; Wang H; Li W Microvasc Res; 2024 Jan; 151():104600. PubMed ID: 37666318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]